recomendaciones para la atenci√≥n de pacientes con insuficiencia cardiaca y covid-19 recommendations for the care of patients with heart failure and covid-19. Copyright: ¬© 2020 Permanyer.The COVID-19 pandemic decreed by the World Health Organization (WHO) since March 12, 2020 is wreaking havoc globally and it is a true economic, social and health challenge. Although the clinical manifestations of COVID-19 are respiratory symptoms, some patients also have cardiological symptoms. Among patients with cardiological conditions2 they represent a group of higher risk and, in fact, they are a particularly vulnerable group, due to their higher risk of contagion and greater severity in case of acquiring the disease1 those with heart failure (HF), including heart transplant (CT) and ventricular assists, as well as patients with pulmonary arterial hypertension (PAH). HF is the main chronic cardiovascular disease and patients in this group are the most vulnerable for the development of more serious clinical symptoms after suffering the infection, and to a greater extent cases with advanced HF3. In fact, HF is one of the most frequent complications in patients with COVID-194. Likewise, transplant patients who require immunosuppressants to avoid graft rejection, constitute a population especially susceptible to infection and to develop more serious processes. This situation has made the National Association of Cardiologists of Mexico (ANCAM) and the Mexican Society of Cardiology (SMC) together with their respective chapters, have prepared the following recommendations for medical personnel, who participate in the care of this special group of patients in the different clinical settings, who suffer or not, of COVID-19.La pandemia por COVID-19 decretada por la Organizaci√≥n Mundial de la Salud (OMS) desde el 12 de marzo de 2020 est√° produciendo estragos a nivel mundial y es un verdadero reto econ√≥mico, social y sanitario. Aunque las manifestaciones cl√≠nicas del COVID-19 son s√≠ntomas respiratorios, algunos pacientes tambi√©n tienen s√≠ntomas cardiol√≥gicos. Dentro de los pacientes con afecciones cardiol√≥gicas2 suponen un grupo de mayor riesgo y que de hecho son un grupo especialmente vulnerable, por su mayor riesgo de contagio y mayor gravedad en caso de adquirir la enfermedad1 aquellos con insuficiencia cardiaca (IC), incluyendo al trasplante cardiaco (TC) y las asistencias ventriculares, as√≠ como los pacientes con hipertensi√≥n arterial pulmonar (HAP). La IC es la principal patolog√≠a cardiovascular cr√≥nica y los pacientes en este grupo son los m√°s vulnerables para el desarrollo de cuadros cl√≠nicos m√°s graves tras sufrir la infecci√≥n, y en mayor medida los casos con IC avanzada3. De hecho, la IC es unas de las complicaciones m√°s frecuentes en los pacientes con COVID-194. De igual forma, los pacientes trasplantados que requieren de los inmunosupresores para evitar el rechazo del injerto, constituyen una poblaci√≥n especialmente susceptible a la infecci√≥n y a desarrollar procesos m√°s graves. Esta situaci√≥n ha hecho que la Asociaci√≥n Nacional de Cardi√≥logos de M√©xico (ANCAM) y la Sociedad Mexicana de Cardiolog√≠a (SMC) junto con sus respectivos cap√≠tulos, hayan elaborado las siguientes recomendaciones para el personal m√©dico, que participa en la atenci√≥n de este grupo especial de pacientes en los diferentes escenarios cl√≠nicos, que padezcan o no, COVID-19.